|1|Current treatment and management of dystrophinopathies. (24619767)
Goemans N.... Buyse G.
|2|Bmi1 enhances skeletal muscle regeneration through MT1-mediated oxidative stress protection in a mouse model of dystrophinopathy. (25452464)
Di Foggia V.... Marino S.
|3|Molecular diagnosis of dystrophinopathies using a multi-technique analysis algorithm. (23695957)
Luce L.N.... Giliberto F.
|4|Motor unit potentials with satellites in dystrophinopathies. (23369874)
Zalewska E.... Hausmanowa-Petrusewicz I.
|5|Pre-clinical drug tests in the mdx mouse as a model of dystrophinopathies: an overview. (22655516)
De Luca A.
|6|Assessment of cardiac function in three mouse dystrophinopathies by magnetic resonance imaging. (22209498)
Verhaart I.E.... van der Weerd L.
|7|Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations? (21305657)
Khelifi M.M.... Tuffery-Giraud S.
|9|Symptomatic dystrophinopathies in female children. (21186124)
Seemann N.... Campbell C.
|10|Dystrophinopathy in girls with limb girdle muscular dystrophy phenotype. (20516809)
Golla S.... Iannaccone S.T.
|11|Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. (19937601)
Flanigan K.M.... Weiss R.B.
|12|Association of autistic spectrum disorders with dystrophinopathies. (19818935)
Hinton V.J.... De Vivo D.C.
|13|Muscle pain as the only presenting symptom in a girl with dystrophinopathy. (18054699)
Ceulemans B.P.... Martin J.J.
|14|Cardiac involvement in the dystrophinopathies. (21791770)
Russell M.W.... Metzger J.M.
|15|Characterization of initiator and effector caspase expressions in dystrophinopathies. (16521476)
|16|Mutation spectrum leading to an attenuated phenotype in dystrophinopathies. (16077730)
Tuffery-Giraud S.... Claustres M.
|17|Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohort. (15723292)
Dent K.M.... Flanigan K.M.
|18|Tumour necrosis factor-mediated cell death pathways do not contribute to muscle fibre death in dystrophinopathies. (15791480)
|19|Evolving therapeutic strategies for dystrophinopathies: potential for conflict between cardiac and skeletal needs. (16267247)
|20|Dystrophinopathy caused by mid-intronic substitutions activating cryptic exons in the DMD gene. (14659407)
BAcroud C.... Leturcq F.
|21|Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR. (14999492)
Arning L.... Gencik M.
|22|Immunopathology and molecular genetics of dystrophinopathies. (16106629)
Brown S.C.... Sewry C.A.
|23|Two alternative exons can result from activation of the cryptic splice acceptor site deep within intron 2 of the dystrophin gene in a patient with as yet asymptomatic dystrophinopathy. (12522557)
Yagi M.... Matsuo M.
|24|The heart in human dystrophinopathies. (12589117)
Finsterer J.... StAPllberger C.
|25|Diagnosis of dystrophinopathy by skin biopsy. (11870717)
Niiyama T.... Osame M.
|26|Dystrophinopathies: peculiar clinical and laboratory aspects. (11996522)
Berardinelli A.... Lanzi G.
|27|Nonsense mutation of the alpha-actinin-3 gene is not associated with dystrophinopathy. (10797427)
Suminaga R.... Wada H.
|28|Dystrophinopathies in females. (11057028)
Hausmanowa-Petrusewicz I.... Bojakowski J.
|29|Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. (10466417)
Siciliano G.... Murri L.
|30|On dystrophin abundance and C-terminal missense mutations in dystrophinopathies. (10401797)
Oexle K.... Heyer R.
|31|Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse. (10672510)
|32|The dystrophinopathies: an alternative to the structural hypothesis. (9702783)
|33|From dystrophinopathy to sarcoglycanopathy: evolution of a concept of muscular dystrophy. (9533777)
Ozawa E.... Yoshida M.
|34|Dystrophinopathy, the expanding phenotype. Dystrophin abnormalities in X-linked dilated cardiomyopathy. (9170393)
|35|Exertional rhabdomyolysis and exercise intolerance revealing dystrophinopathies. (9224530)
Figarella-Branger D.... Pellissier J.F.
Reitter B.... Goebel H.H.
|37|The differential diagnosis of the human dystrophinopathies and related disorders. (8894415)
|38|Prognostic factors in mild dystrophinopathies. (8902723)
Angelini C.... Danieli G.A.
|39|Dystrophinopathies: clarification and complication. (8745379)
SAMAHA F.J.... Quinlan J.G.
|40|HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies. (9018456)
Hoffman E.P.... Clemens P.R.
|41|Phenotype of dystrophinopathy in old mdx mice. (7604983)
Lefaucheur J.P.... Sebille A.
|42|X-chromosome methylation in manifesting and healthy carriers of dystrophinopathies: concordance of activation ratios among first degree female relatives and skewed inactivation as cause of the affected phenotypes. (7635465)
Azofeifa J.... Cremer M.
|43|Phospholipase A2 activity in dystrophinopathies. (7633184)
Lindahl M.... Hoffman E.P.
Gallano P.... Baiget M.
|45|Dystrophin, its gene, and the dystrophinopathies. (7484453)
|46|Immunohistochemistry in the diagnosis of dystrophinopathies. (7547371)
|47|Dystrophinopathy presenting as congenital muscular dystrophy. (7981596)
Kyriakides T.... Middleton L.
|48|Anaesthesia-induced rhabdomyolysis causing cardiac arrest: case report and review of anaesthesia and the dystrophinopathies. (7818067)
|49|Dystrophinopathy in two young boys with exercise-induced cramps and myoglobinuria. (8223790)
Minetti C.... Bonilla E.
|50|Diagnosis of dystrophinopathies: review for the clinician. (8452597)
Miller G.... Wessel H.B.